SCHEMA | BGB Market Access

This #PrideMonth, SCHEMA celebrates contributions of LGBTQ+ individuals across the pharmaceutical and market access landscape. We're proud to stand with the LGBTQ+ community—this month and all months—in support of equality for all. #Pride2025 #LovelsLove #Equality

As a market access agency, SCHEMA is helping our clients navigate the intersection of innovation and evidence - translating Al breakthroughs into compelling value narratives that resonate with decision-makers. It's not just about fancy, new tech - it's about using AI in smart ways to help patients access new treatments. Contact SCHEMA to learn more about how our Al capabilities can help. #MarketAccess #AlinHealthcare #DigitalHealth #HealthEconomics #RealWorldEvidence 

During this ALS ( Amyotrophic lateral sclerosis) Awareness Month, we're recognizing organizations and individuals who are pushing to make a difference and redefine this disease. ALS is a progressive, fatal neuromuscular disease that can strike regardless of age, gender, nationality, or ethnicity. While there is no known cure today, supporting ways to unite the community and fundraise for research is crucial to ensure this space sees the innovation it deserves. We're supporting our colleague Julie Yoon and her efforts to reach her goal in time for the ALS United walk this coming September. Visit the link below or reach out if you would like to donate and/or join in the walk with more than 50,000 others! https://rb.gy/i6utsm #ALSAwarenessMonth #ALSUnited

Over 30-million Americans have been diagnosed with a rare disease, however only 10% of these conditions have an FDA approved treatment option. The good news is that there are over 700 drugs in the #pharma pipeline targeting rare diseases. Despite the promising new treatments on the way, significant hurdles will inevitably hinder patients from accessing newly approved drugs. At SCHEMA, we focus on helping to overcome these barriers and expedite patient #access to these essential treatments. #SCHEMACares4Rare #CareForRare #RareDisease 

The market access space is an ever-changing, fluid landscape. Policy shifts, increasing costs, and generic entrants to the market are just three of the many factors manufacturers need to navigate on a day-to-day basis. How are you keeping up with the dynamic #MarketAccess space?

Despite requiring 10% more healthcare services than men, women are 35% more likely than men to say they’ve skipped or delayed medical care. On this #WomensHealthWeek, join SCHEMA in advocating for solutions that improve access to care and health outcomes for women. #MarketAccess #WomensHealth

Last month, SCHEMA hosted a workshop at the World Orphan Drug Congress USA in Boston. Our workshop gathered participants across a range of rare disease stakeholders, including pharma value and access teams, patient advocacy groups, and more. This report represents our biggest takeaways from that learning session, highlighting identified barriers to access across the patient journey, as well as potential opportunities to help close access gaps. To learn how SCHEMA can support your unique market access needs, send us a message!

We're excited to introduce the latest addition to the SCHEMA account team, Heather Finley! An enthusiastic yogi who finds her inner balance on the #yoga mat, Heather is also an adept #tennis player and has a sequestered fondness for a #karaoke night. #Hiring #NewHire

SCHEMA's favorite furry friends would like to wish you—and more importantly your own fluffy companions—a Happy National Pet Week! #Dogs #Cats #PetLove #NationalPetWeek